News

CATEGORIES

CONTACT THE MEDIA TEAM

If you are a journalist with questions or an interview or media request, please do not hesitate to contact us.
CONTACT US

Archive

see all

Recent Posts

Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases

by Diane Hunt on 2/7/20 1:38 PM News

Learn More
All Posts
Follow Us
Join us on LinkedIn Follow us on Twitter

Events

Oculis Selects AGC Biologics’ Heidelberg Facility to Manufacture OCS-02
BIO International Convention goes Virtual June 8 - 11, 2020
BioProcess International European Summit, July 13-16, 2020, Amsterdam
MIXiii BIOMED, September 7-9, 2020, Tel Aviv, Israel
Bio-Europe will be held October 26 - 28, 2020, Munich Germany

News

AGC Biologics Enters Agreement to Acquire Facility in Longmont, CO, Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities and Offerings
Chemomab Therapeutics and AGC Biologics Expand Partnership to Manufacture CM-101 for Phase II/III
AGC Biologics’ Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine
AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics
AGC Biologics Expands Partnership with Rocket Pharmaceuticals

LOCATIONS

SEATTLE, WASHINGTON (Headquarters)

BOULDER, COLORADO

COPENHAGEN, DENMARK

HEIDELBERG, GERMANY

MILAN, ITALY

CHIBA, JAPAN

 ©2020 AGC Biologics. All Rights Reserved.         Website Privacy Policy